Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2009
03/12/2009US20090069180 2-substituted pyrimidine derivatives
03/12/2009US20090068140 Hepatitis c virus inhibitors
03/12/2009US20090068105 Isatin analogues and uses therefor
03/12/2009US20090066231 Electroluminescent device
03/12/2009CA2704284A1 Co-crystals and pharmaceutical compositions comprising the same
03/12/2009CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
03/12/2009CA2698341A1 Gamma secretase modulators
03/12/2009CA2697934A1 1,3-dihydroisoindole derivatives
03/12/2009CA2697454A1 2-carboxy substituted indole derivatives and methods of use thereof
03/12/2009CA2696824A1 Compounds and compositions as kinase inhibitors
03/12/2009CA2684037A1 Compounds with anti-cancer activity
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2032570A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032566A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032559A1 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
03/11/2009EP2032558A1 Benzazepine derivatives as monoamine reuptake inhibitors
03/11/2009EP2032554A1 Piperidinyl pyrimidine derivatives
03/11/2009EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines
03/11/2009EP2032542A2 Heterocyclic aspartyl protease inhibitors
03/11/2009EP2032530A1 Pyrrolidine compounds as renin inhibitors
03/11/2009EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists
03/11/2009EP1620440B1 Synthesis of substituted heterocyclic compounds
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
03/11/2009EP1358165B1 Imidazole derivatives
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1319659B1 Triazinones and medicinal use thereof
03/11/2009EP1317445B1 Chemokine receptor binding heterocyclic compounds
03/11/2009EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk)
03/11/2009CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases
03/11/2009CN101384559A Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/11/2009CN101384558A Gaba-b receptor modulators
03/11/2009CN101384554A Pyridine-2-carboxamide derivatives
03/11/2009CN101384263A Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor
03/11/2009CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
03/11/2009CN100467463C Pyrazolyl indolyl derivatives as PPAR activators
03/11/2009CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/10/2009US7501525 Derivatives of benzimidazole and their use as medicaments
03/10/2009US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents
03/10/2009US7501523 reacting an oligomer consisting of 2-11 linked glycolurils or analogues with one or more compounds selected from glycoluril, glycoluril analogues and/or oligomers of glycoluril or glycoluril analogues, in the presence of an acid, and a template (dimethylaminobenzaldehyde) to form a cucurbit(n)uril
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501510 N,N'-disubstituted thiourea ligand, when complexed with palladium forms a catalyst useful for Heck reaction of arylhalides and olefins and Suzuki cross-coupling reaction of aryl halides with aryl boric acids
03/10/2009US7501436 To treat irritable bowel syndrome; side effect reduction, improved pharmacodynamics and safety, more potent and selective; 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group
03/10/2009US7501422 Prolinamide-tetrazole derivatives as NK3 receptor antagonists
03/10/2009US7501419 4-Squarylpiperazine derivatives as antiviral agents
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501415 Selective inhibitors of ERK protein kinase and uses thereof
03/10/2009US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/10/2009US7501404 Substituted azetidinones
03/10/2009CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
03/05/2009WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors
03/05/2009WO2009029499A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/05/2009WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/05/2009WO2009029375A1 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009028588A1 Polycyclic compound
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide
03/05/2009WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
03/05/2009WO2009026701A1 Sirtuin inhibitors
03/05/2009WO2009005690A3 Antiviral compounds
03/05/2009WO2009005677A3 Antiviral compounds
03/05/2009WO2009005676A3 Antiviral compounds
03/05/2009WO2008147812A3 4' substituted compounds having 5-ht6 receptor affinity
03/05/2009WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors
03/05/2009WO2008138448A3 Heterocyclic indazole derivatives
03/05/2009WO2008137622A3 Aminopyrimidines useful as kinase inhibitors
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009WO2008012441A3 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses
03/05/2009US20090062551 Elastic materials
03/05/2009US20090062541 Reacting an aryl or heteroaryl halide with a cyanide donor,potassium hexacyanoferrate(II) or (III), in the presence of a copper compound and a 1-alkyl imidazole as a catalyst stabilizer); nontoxic; industrial scale; cost efficiency; chemical intermediates for agrochemicals and pharmaceuticals
03/05/2009US20090062540 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/05/2009US20090062537 N-Formyl Hydrozyamine Compounds
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062517 Dissymmetrical Diazo Compounds Containing Having at Least One 2-imidazolium Unit and a Cationic or Non-cationic Linker, Compositions Comprising Them, Method of Coloring, and Device
03/05/2009US20090062367 Deuterium-enriched eletriptan
03/05/2009US20090062358 Peroxisome proliferator activated receptor alpha agonists
03/05/2009US20090062357 Deuterium-enriched fluconazole
03/05/2009US20090062310 Deuterium-enriched voriconazole
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009US20090062306 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
03/05/2009US20090062304 Benzimidazole derivatives and their use for modulating the gaba-alpha receptor complex
03/05/2009US20090062299 Deuterium-enriched doxazosin
03/05/2009US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
03/05/2009US20090062293 1,4-Substituted Piperazine Derivatives
03/05/2009US20090062289 Immunomodulating oxopyrrazolocinnolines as cd 80 inhibitors
03/05/2009US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
03/05/2009US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use
03/05/2009US20090058289 Materials for Organic Electroluminescent Devices
03/05/2009US20090056587 Compound, Ink, Process And Use
03/05/2009DE102007041116A1 1,3-Dihydro-isoindolderivate 1,3-dihydro-isoindolderivate
03/05/2009CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009CA2697663A1 Substituted pyrazole derivative
03/05/2009CA2697368A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/05/2009CA2694911A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/04/2009EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 626